{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:51:56Z","timestamp":1794109916184,"version":"4.8.0"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Bladder cancer (BC) is a disease that predominantly affects older adults, with aging playing a critical role in its onset and progression. Age-associated phenomena, including immunosenescence and chronic inflammation, form a pro-tumor milieu, while genomic instability and epigenetic drift further increase cancer risk. The review highlights the dual role of DNA methylation in BC: global hypomethylation can activate transposable elements and oncogenes, whereas focal hypermethylation silences tumor-suppressor genes like CDKN2A, especially detrimental in older tissues that rely on these genes for senescence control. In parallel, frequent mutations in chromatin modifiers (e.g., KDM6A, KMT2D) and overexpression of histone-modifying enzymes (e.g., EZH2) alter the tumor epigenome to promote immune evasion and tumor aggressiveness. At the non-coding RNA level, dysregulated microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in BC contribute to aberrant proliferation, metastatic potential, and immune suppression, with aging-associated declines in miRNA processing further exacerbating these effects. Collectively, the accumulation of epigenetic alterations in older patients appears to facilitate both tumor progression and resistance to therapy. Looking forward, epigenetic biomarkers may improve early detection and risk stratification. Furthermore, \u201cepigenetic therapies,\u201d such as DNA methyltransferase inhibitors (DNMTi), EZH2 inhibitors (EZH2i), or histone deacetylases inhibitors (HDACi), hold promise to restore tumor-suppressor function and enhance immunogenicity, offering an attractive avenue for improving outcomes in older patients with BC.<\/jats:p>","DOI":"10.3389\/fphar.2025.1617452","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T05:28:13Z","timestamp":1755754093000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Epigenetic regulation of bladder cancer in the context of aging"],"prefix":"10.3389","volume":"16","author":[{"given":"Xuewei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1148\/radiol.2020191770","article-title":"Muscle-invasive urothelial cancer: association of mutational status with metastatic pattern and survival","volume":"295","author":"Alessandrino","year":"2020","journal-title":"Radiology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/cells12192392","article-title":"Aging and age-related epigenetic drift in the pathogenesis of leukemia and lymphomas: new therapeutic targets","volume":"12","author":"Allegra","year":"2023","journal-title":"Cells"},{"key":"B3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10522-025-10194-2","article-title":"The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer","volume":"26","author":"Balaraman","year":"2025","journal-title":"Biogerontology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3390\/genes15121599","article-title":"Epigenetic mechanisms in aging: extrinsic factors and gut microbiome","volume":"15","author":"Borrego-Ruiz","year":"2024","journal-title":"Genes"},{"key":"B5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10522-020-09874-y","article-title":"Epigenetic changes during ageing and their underlying mechanisms","volume":"21","author":"Braga","year":"2020","journal-title":"Biogerontology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13046-019-1030-5","article-title":"Emerging roles of telomeric chromatin alterations in cancer","volume":"38","author":"Cacchione","year":"2019","journal-title":"J. Exp. and Clin. Cancer Res. CR"},{"key":"B7","doi-asserted-by":"publisher","first-page":"120113","DOI":"10.1016\/j.cca.2024.120113","article-title":"Urinary miRNAs in bladder cancer","volume":"567","author":"Chattopadhaya","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-18-1656","article-title":"Long noncoding RNA LBCS inhibits self-renewal and chemoresistance of bladder cancer stem cells through epigenetic silencing of SOX2","volume":"25","author":"Chen","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s12885-021-08372-9","article-title":"Significance of KDM6A mutation in bladder cancer immune escape","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"847629","DOI":"10.3389\/fbinf.2022.847629","article-title":"DNA methylation, aging, and cancer risk: a mini-review","volume":"2","author":"Chen","year":"2022","journal-title":"Front. Bioinforma."},{"key":"B11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/carcin\/bgad058","article-title":"On the road to colorectal cancer development: crosstalk between the gut microbiota, metabolic reprogramming, and epigenetic modifications","volume":"44","author":"Chen","year":"","journal-title":"Carcinogenesis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1158\/1055-9965.EPI-23-0331","article-title":"Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes","volume":"32","author":"Chen","year":"","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cell.2017.06.017","article-title":"TERRA RNA antagonizes ATRX and protects telomeres","volume":"170","author":"Chu","year":"2017","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mad.2017.12.002","article-title":"DNA methylation dynamics in aging: how far are we from understanding the mechanisms?","volume":"174","author":"Ciccarone","year":"2018","journal-title":"Mech. Ageing Dev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"100814","DOI":"10.1016\/j.neo.2022.100814","article-title":"Therapeutic significance of ARID1A mutation in bladder cancer","volume":"31","author":"Conde","year":"2022","journal-title":"Neoplasia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.3390\/cancers16132357","article-title":"The significant associations between epigenetic clocks and bladder cancer risks","volume":"16","author":"Deng","year":"2024","journal-title":"Cancers"},{"key":"B17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41389-023-00489-9","article-title":"Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions","volume":"12","author":"Doshi","year":"2023","journal-title":"Oncogenesis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/path.6164","article-title":"Escape from senescence: molecular basis and therapeutic ramifications","volume":"260","author":"Evangelou","year":"2023","journal-title":"J. Pathology"},{"key":"B19","volume-title":"The clinical landscape of DNA methylation inhibitors in cancer therapy","author":"Galustjan","year":"2023"},{"key":"B20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/pros.23714","article-title":"miR-21-5p, miR-141-3p, and miR-205-5p levels in urine\u2014promising biomarkers for the identification of prostate and bladder cancer","volume":"79","author":"Ghorbanmehr","year":"2019","journal-title":"Prostate"},{"key":"B21","doi-asserted-by":"publisher","first-page":"12767","DOI":"10.3390\/ijms241612767","article-title":"MiRNA-146a\u2014a key player in immunity and diseases","volume":"24","author":"Gilyazova","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9854","DOI":"10.3390\/ijms24129854","article-title":"Epigenetic and immunological features of bladder cancer","volume":"24","author":"Gilyazova","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/uro4030012","article-title":"Bladder cancer basic study and current clinical trials","volume":"4","author":"Godlewski","year":"2024","journal-title":"Uro"},{"key":"B24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13148-022-01240-8","article-title":"Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation","volume":"14","author":"Hentschel","year":"2022","journal-title":"Clin. Epigenetics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","article-title":"DNA methylation age of human tissues and cell types","volume":"14","author":"Horvath","year":"2013","journal-title":"Genome Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13148-021-01154-x","article-title":"DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application","volume":"13","author":"Hu","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2022.10.015","article-title":"Methylation biomarkers for early cancer detection and diagnosis: current and future perspectives","volume":"178","author":"Ibrahim","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/JCI69735","article-title":"Aging and epigenetic drift: a vicious cycle","volume":"124","author":"Issa","year":"2014","journal-title":"J. Clin. Investigation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2010.07.012","article-title":"MicroRNA-34a regulation of endothelial senescence","volume":"398","author":"Ito","year":"2010","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1111\/cas.15040","article-title":"Phase II study of tazemetostat for relapsed or refractory b\u2010cell non\u2010hodgkin lymphoma with EZH2 mutation in Japan","volume":"112","author":"Izutsu","year":"2021","journal-title":"Cancer Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1134\/S0006297918110019","article-title":"Regulation of tumor suppressor gene CDKN2A and encoded P16-INK4a protein by covalent modifications","volume":"83","author":"Jiao","year":"2018","journal-title":"Biochem. Mosc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the Let-7 MicroRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molimm.2021.05.009","article-title":"Playing hide and seek: tumor cells in control of MHC class I antigen presentation","volume":"136","author":"Jongsma","year":"2021","journal-title":"Mol. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fsigen.2018.09.010","article-title":"DNA methylation of the ELOVL2, FHL2, KLF14, C1orf132\/MIR29B2C, and TRIM59 genes for age prediction from blood, saliva, and buccal swab samples","volume":"38","author":"Jung","year":"2019","journal-title":"Forensic Sci. Int. Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"eaar5598","DOI":"10.1126\/sciadv.aar5598","article-title":"X chromosome protects against bladder cancer in females via a KDM6A-Dependent epigenetic mechanism","volume":"4","author":"Kaneko","year":"2018","journal-title":"Sci. Adv."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2217\/epi-2020-0186","article-title":"EZH2 inhibition: a promising strategy to prevent cancer immune editing","volume":"12","author":"Kang","year":"2020","journal-title":"Epigenomics"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.23.21252194","article-title":"Do epigenetic clocks provide explanations for sex differences in lifespan?","author":"Kankaanp\u00e4\u00e4","year":"2021","journal-title":"A Cross-Sectional Twin Study"},{"key":"B39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12979-021-00240-1","article-title":"miR-181a-Regulated pathways in T-Cell differentiation and aging","volume":"18","author":"Kim","year":"2021","journal-title":"Immun. and Ageing"},{"key":"B40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1158\/1078-0432.CCR-19-2230","article-title":"Kdm6a deficiency activates inflammatory pathways, promotes M2 macrophage polarization, and causes bladder cancer in cooperation with P53 dysfunction","volume":"26","author":"Kobatake","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"B43","doi-asserted-by":"publisher","first-page":"9327","DOI":"10.1073\/pnas.1604558113","article-title":"Menopause accelerates biological aging","volume":"113","author":"Levine","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1327","DOI":"10.1038\/cddis.2014.270","article-title":"MicroRNA-34a: a potential therapeutic target in human cancer","volume":"5","author":"Li","year":"","journal-title":"Cell Death Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/cas.12461","article-title":"Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR\u2013STAT3\/microRNA143 pathway","volume":"105","author":"Li","year":"","journal-title":"Cancer Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2020.04.023","article-title":"Non-coding RNA in bladder cancer","volume":"485","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"672679","DOI":"10.3389\/fcell.2021.672679","article-title":"Role of long non-coding RNAs on bladder cancer","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.18632\/aging.102225","article-title":"An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer","volume":"11","author":"Lian","year":"2019","journal-title":"Aging"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.csbj.2020.05.001","article-title":"Rewired functional regulatory networks among miRNA isoforms (isomiRs) from Let-7 and miR-10 gene families in cancer","volume":"18","author":"Liang","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1005334","DOI":"10.1371\/journal.pgen.1005334","article-title":"Epigenetic aging signatures are coherently modified in cancer","volume":"11","author":"Lin","year":"2015","journal-title":"PLOS Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.urolonc.2008.12.008","article-title":"Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-Cadherin, P16, P14, RASSF1A genes in urine. Urologic oncology: seminars and original investigations","volume":"28","author":"Lin","year":"2010","journal-title":"Proc. 2009 World Urologic Oncol. Fed. Conf."},{"key":"B52","doi-asserted-by":"publisher","first-page":"10732748231152322","DOI":"10.1177\/10732748231152322","article-title":"Impact of age at diagnosis of bladder cancer on survival: a surveillance, epidemiology, and end results-based study 2004-2015","volume":"30","author":"Lin","year":"2023","journal-title":"Cancer Control J. Moffitt Cancer Cent."},{"key":"B53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13148-021-01046-0","article-title":"Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy","volume":"13","author":"Lodewijk","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.3390\/cancers12103054","article-title":"A methylation-based reclassification of bladder cancer based on immune cell genes","volume":"12","author":"Luo","year":"2020","journal-title":"Cancers"},{"key":"B56","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.3892\/ol.2017.6886","article-title":"LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143\/HMGB1 pathway","volume":"14","author":"Luo","year":"2017","journal-title":"Oncol. Lett."},{"key":"B57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41585-022-00611-3","article-title":"Bladder cancer, inflammageing and microbiomes","volume":"19","author":"Martin","year":"2022","journal-title":"Nat. Rev. Urol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13148-015-0141-x","article-title":"Analysis of the polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer","volume":"7","author":"Mart\u00ednez-Fern\u00e1ndez","year":"","journal-title":"Clin. Epigenetics"},{"key":"B59","doi-asserted-by":"publisher","first-page":"27107","DOI":"10.3390\/ijms161126000","article-title":"EZH2 in bladder cancer, a promising therapeutic target","volume":"16","author":"Mart\u00ednez-Fern\u00e1ndez","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13059-021-02398-9","article-title":"Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging","volume":"22","author":"McCartney","year":"2021","journal-title":"Genome Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/2040620716674677","article-title":"Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes","volume":"8","author":"Navada","year":"2017","journal-title":"Ther. Adv. Hematol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","article-title":"Non-coding RNAs in disease: from mechanisms to therapeutics","volume":"25","author":"Nemeth","year":"2024","journal-title":"Nat. Rev. Genet."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/cells9081850","article-title":"DNA methylation as a therapeutic target for bladder cancer","volume":"9","author":"Nunes","year":"2020","journal-title":"Cells"},{"key":"B64","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1515\/hsz-2019-0436","article-title":"EZH2 function in immune cell development","volume":"401","author":"Nutt","year":"2020","journal-title":"Biol. Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/his.13032","article-title":"Both cancerous miR-21 and stromal miR-21 in urothelial carcinoma are related to tumour progression","volume":"69","author":"Ohno","year":"2016","journal-title":"Histopathology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"393","DOI":"10.7555\/JBR.30.20160040","article-title":"New insights into estrogenic regulation of O6-Methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: co-degradation of ER-\u03b1 and MGMT proteins by fulvestrant or O6-Benzylguanine indicates fresh avenues for therapy","volume":"30","author":"Paranjpe","year":"2016","journal-title":"J. Biomed. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"102204","DOI":"10.1016\/j.arr.2024.102204","article-title":"Epigenetic reprogramming as a key to reverse ageing and increase longevity","volume":"95","author":"Pereira","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"eabo8043","DOI":"10.1126\/sciadv.abo8043","article-title":"Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma","volume":"8","author":"Piunti","year":"2022","journal-title":"Sci. Adv."},{"key":"B69","doi-asserted-by":"publisher","first-page":"101087","DOI":"10.1016\/j.arr.2020.101087","article-title":"The critical impacts of small RNA biogenesis proteins on aging, longevity and age-related diseases","volume":"62","author":"Proshkina","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/s41418-019-0278-9","article-title":"Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer","volume":"26","author":"Ramakrishnan","year":"2019","journal-title":"Cell Death Differ."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3390\/cancers14061364","article-title":"Cytokine-induced senescence in the tumor microenvironment and its effects on anti-tumor immune responses","volume":"14","author":"Rentschler","year":"2022","journal-title":"Cancers"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/life12091332","article-title":"P16INK4A\u2014More than a senescence marker","volume":"12","author":"Safwan-Zaiter","year":"2022","journal-title":"Life"},{"key":"B73","doi-asserted-by":"publisher","first-page":"486","DOI":"10.20517\/evcna.2023.29","article-title":"MicroRNA biogenesis pathway alterations in aging","volume":"4","author":"Sanz-Ros","year":"2023","journal-title":"Extracell. Vesicles Circulating Nucleic Acids"},{"key":"B74","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fimmu.2013.00226","article-title":"Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis","volume":"4","author":"Schilderink","year":"2013","journal-title":"Front. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/ijc.32116","article-title":"The histone demethylase UTX\/KDM6A in cancer: progress and puzzles","volume":"145","author":"Schulz","year":"2019","journal-title":"Int. J. Cancer"},{"key":"B76","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1053\/j.seminoncol.2022.06.005","article-title":"Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer","volume":"49","author":"Shin","year":"2022","journal-title":"Seminars Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.2174\/1568026619666181210152115","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"18","author":"Sun","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"155572","DOI":"10.1016\/j.prp.2024.155572","article-title":"MicroRNA-21 (miR-21) in breast cancer: from apoptosis dysregulation to therapeutic opportunities","volume":"262","author":"Syed","year":"2024","journal-title":"Pathology, Res. Pract."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/cells11071113","article-title":"Histone methylases and demethylases regulating antagonistic methyl marks: changes occurring in cancer","volume":"11","author":"Taylor-Papadimitriou","year":"2022","journal-title":"Cells"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3390\/cancers15061856","article-title":"New approaches to targeting epigenetic regulation in bladder cancer","volume":"15","author":"Thompson","year":"2023","journal-title":"Cancers"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e00341-20","DOI":"10.1128\/MCB.00341-20","article-title":"Lysine demethylase KDM6A in differentiation, development, and cancer","volume":"40","author":"Tran","year":"2020","journal-title":"Mol. Cell. Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrd.2017.55","article-title":"Anticancer drugs: all roads lead to EZH2 inhibition","volume":"16","author":"Villanueva","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"B84","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41587-023-01751-6","article-title":"Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissues","volume":"42","author":"Wagner","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2147\/CMAR.S232388","article-title":"The emerging roles of miR-125b in cancers","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/cancers13030427","article-title":"Cancer treatment-induced accelerated aging in cancer survivors: biology and assessment","volume":"13","author":"Wang","year":"","journal-title":"Cancers"},{"key":"B87","doi-asserted-by":"publisher","first-page":"615340","DOI":"10.3389\/fgene.2021.615340","article-title":"Functional network of the long non-coding RNA growth arrest-specific transcript 5 and its interacting proteins in senescence","volume":"12","author":"Wang","year":"","journal-title":"Front. Genet."},{"key":"B88","doi-asserted-by":"publisher","first-page":"104873","DOI":"10.1016\/j.jddst.2023.104873","article-title":"Application of targeted drug delivery based on nano platform in diagnosis and treatment of bladder cancer","volume":"87","author":"Wang","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41588-024-02015-y","article-title":"Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A\u2013Menin to bivalent promoters","volume":"57","author":"Wang","year":"2025","journal-title":"Nat. Genet."},{"key":"B90","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.3390\/cancers13163933","article-title":"Intravesical instillation of azacitidine suppresses tumor formation through TNF-R1 and TRAIL-R2 signaling in genotoxic carcinogen-induced bladder cancer","volume":"13","author":"Wang S. -C.","year":"2021","journal-title":"Cancers"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/ijc.33359","article-title":"Recurrent bladder cancer in aging societies: importance of major histocompatibility complex class I antigen presentation","volume":"148","author":"Wieczorek","year":"2021","journal-title":"Int. J. Cancer"},{"key":"B92","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/cas.12844","article-title":"Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1\/2-FSCN1 pathway","volume":"107","author":"Xue","year":"2015","journal-title":"Cancer Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"654718","DOI":"10.3389\/fmolb.2021.654718","article-title":"Up-Regulating ERIC by CRISPR-dCas9-VPR inhibits cell proliferation and invasion and promotes apoptosis in human bladder cancer","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"760369","DOI":"10.3389\/fcell.2021.760369","article-title":"DNA methylation modification map to predict tumor molecular subtypes and efficacy of immunotherapy in bladder cancer","volume":"9","author":"Ye","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3390\/cancers13081881","article-title":"Epigenetic drift association with cancer risk and survival, and modification by sex","volume":"13","author":"Yu","year":"2021","journal-title":"Cancers"},{"key":"B96","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","article-title":"Cancer epigenetics: from laboratory studies and clinical trials to precision medicine","volume":"10","author":"Yu","year":"2024","journal-title":"Cell Death Discov."},{"key":"B97","doi-asserted-by":"publisher","first-page":"266","DOI":"10.20517\/jtgg.2021.58","article-title":"Estrogen and DNA damage modulate mRNA levels of genes involved in homologous recombination repair in estrogen-deprived cells","volume":"6","author":"Zach","year":"2022","journal-title":"J. Transl. Genet. Genomics"},{"key":"B98","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1476-4598-12-101","article-title":"The complexity of bladder cancer: long noncoding RNAs are on the stage","volume":"12","author":"Zhang","year":"2013","journal-title":"Mol. Cancer"},{"key":"B99","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41389-019-0182-7","article-title":"LncRNA MACC1-AS1 sponges multiple miRNAs and RNA-binding protein PTBP1","volume":"8","author":"Zhang","year":"2019","journal-title":"Oncogenesis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-019-0204-5","article-title":"The ageing epigenome and its rejuvenation","volume":"21","author":"Zhang","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.2147\/IJN.S498729","article-title":"A novel approach for bladder cancer treatment: nanoparticles as a drug delivery system","volume":"19","author":"Zhao","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"692941","DOI":"10.3389\/fmolb.2021.692941","article-title":"Downregulation of CacyBP by CRISPR\/dCas9-KRAB prevents bladder cancer progression","volume":"8","author":"Zheng","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1470148","DOI":"10.3389\/fphar.2024.1470148","article-title":"DNA methylation inhibitors adverse reaction characteristic analysis: a descriptive analysis from WHO-VigiAccess","volume":"15","author":"Zhou","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1233953","article-title":"Frontiers | non-canonical functions of EZH2 in cancer","author":"Zimmerman","year":"2023"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1482765","DOI":"10.3389\/fimmu.2024.1482765","article-title":"Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?","volume":"15","author":"Zou","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1617452\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T05:28:14Z","timestamp":1755754094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1617452\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":105,"alternative-id":["10.3389\/fphar.2025.1617452"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1617452","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"article-number":"1617452"}}